Boai NKY Medical Holdings Ltd. (SHE:300109)

Market Cap	8.11B +2.1%
Revenue (ttm)	1.20B -22.2%
Net Income	174.42M -43.5%
EPS	0.35 -44.8%
Shares Out	483.38M
PE Ratio	47.49
Forward PE	n/a
Dividend	0.20 (1.18%)
Ex-Dividend Date	Jul 10, 2025

Volume	4,721,464
Open	16.50
Previous Close	16.97
Day's Range	16.50 - 17.19
52-Week Range	15.76 - 21.11
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, ag...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1987
• Employees: 1,186
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300109

Financial Performance

In 2025, Boai NKY Medical Holdings's revenue was 1.18 billion, a decrease of -26.66% compared to the previous year's 1.61 billion. Earnings were 190.09 million, a decrease of -45.64%.